# GLO Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glo-pharma

- Industry: Consumer Products
- Headquarters: Carlsbad, US
- Website: www.ourself.com
- Total disclosed funding: $44M
- Latest round: Series B (Sep 9, 2023)
- Investors on record: 2

## About

Founded in 2018 by Vimla Black Gupta, Lauren Otsuki, and Scott Glenn, and based in California, US, GLO Pharma, Inc., trading under the name Ourself, offers skincare products developed using intide, a peptide made out of collagen and elastin to restore the skin without needles and lasers. In August 2021, GLO Pharma, Inc. raised USD 22 million in venture funding from First Round Capital and Lightspeed Venture Partners.

The products developed by the company provide solutions for hyperpigmentation, lips, fine lines and wrinkles. The products include lip filler, lip conditioner, dark spot intercept, dark spot peel, brightening peel, daily renewal cream, mineral sunscreen broad spectrum, etc.

## Funding rounds

- Series B, Sep 9, 2023, $11M — Lightspeed Venture Partners, First Round Capital
- Series B, Jun 10, 2022, $11M — Lightspeed Venture Partners, First Round Capital
- Series B, Feb 3, 2022, $13M — Lightspeed Venture Partners, First Round Capital
- Series B, Aug 30, 2021, $9M — Lightspeed Venture Partners, First Round Capital

## Investors

- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series B
- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Series B